FDA approves Zueino (diclofenac sodium) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Zueino (diclofenac sodium)FDA approves Zueino (diclofenac sodium)25 September 2026The FDA approved Zueino (diclofenac sodium), a drug from Adventapharma. Form: Solution, Intravenous. Application NDA218379.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)